Dong-A PharmTech Co., Ltd. Announces Portal Hypertension Clinical Trial Wit... (underserved portalhypertension market. ...)

Dong-A PharmTech Co., Ltd. Announces Portal Hypertension Clinical Trial With Udenafil

Date:2/25/2008

underserved portal hypertension market."

About Dong-A PharmTech Co., Ltd.

Dong-A PharmTech is a late-stage pharmaceutical company incorporated in Korea, focused on the development and commercialization of udenafil worldwide excluding Korea.

Statements under the Private Securities Litigation Reform Act: with the exception of the historical information contained in this release, the matters described herein contain forward-looking statements that involve risk and uncertainties that may individually or mutually impact the matters herein described, including but not limited to FDA review and approval, product development and acceptance, manufacturing, competition, and/or other factors, which are outside the control of the Company.

Contact:

Mr. Chan Won OH

Director, International Product Development Team

252, Yongdu-Dong, Dongdaemun-Ku

Seoul 130-078, Korea

Tel: +82 2 920 8220

Fax: +82 2 925 4026

Email: ocw@donga.co.kr

SOURCE Dong-A PharmTech Co., Ltd.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine technology :

1. MacuSight(TM) Announces Positive Preliminary Results From Phase 1 Study of Sirolimus in Wet Age-Related Macular Degeneration
2. InteKrin Therapeutics Announces Initiation of Phase 2b Study in Type 2 Diabetes with INT131
3. amfAR Announces Funding for HIV Services and Research Aimed at Men Who Have Sex With Men in Developing Countries
4. ATS Medical Announces Initial Clinical Results of Stand-Alone Atrial Fibrillation Procedures Using ATS CryoMaze Product Line
5. ISTA Pharmaceuticals Announces Physician-Sponsored Clinical Study of Xibrom(TM) Combination Therapy with Lucentis(R)
6. Accumetrics Announces $28.8 Million Financing and Initiation of Pivotal Clinical Trial
7. Bionovo Announces Positive Developments in On-going Phase 1/2 Cancer Drug Trial
8. On Second Anniversary, Compendia Bioscience Announces Significant Revenue Growth, Completion of Product Milestone and Expansion of Pharma Customer Commitments
9. Innocoll Announces Dosing of First Patient in Second US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections
10. Advanced Life Sciences Announces Successful Thorough QT Study of Cethromycin
11. Poniard Pharmaceuticals Announces Positive First-line Phase 1 Safety and Efficacy Data With Picoplatin in Metastatic Prostate Cancer Patients

Post Your Comments:

(Date:11/20/2009)...e/ -- Reportlinker.com announces that a new market..., Global Markets for Assisted Reproductive Devi...4742/Global-Markets-for-Assisted-Reproductive-Devi...=pr&utm_campaign=prnewswire ,, Global Mar... Countries in Europe and Japan. This report includ...

(Date:11/20/2009)...irstCall/ -- Cyberonics, Inc. (Nasdaq: CYBX ) tod...xecutive Officer, and Greg Browne, Chief Financial...ffray Health Care Conference in New York on Wednes...ence session and webcast will be audio only and no...ill host a webcast of the presentation live and by...

(Date:11/20/2009)...swire-FirstCall/ -- Soligenix, Inc. (OTC Bulletin ...known as DOR BioPharma, Inc., a late-stage biotech... a consortium to develop thermostable technology t...nes. Soligenix received a $9.4 million grant from ...iseases (NIAID), a division of the National Instit...

[0] Reportlinker Adds Global Markets for Assisted Reproductive Devices 2009 [0] Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference [0] Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines

...ics, Inc.,(Nasdaq: PCYC ) today announced that i...calation study to evaluate the safety and tolerabi...nhibitor of Bruton,s tyrosine kinase, or Btk,as a ...refractory B-cell,non-Hodgkin,s lymphoma (NHL). ...sted in humans, and is Pharmacyclics, fourth produ...

...ncy, Binding Capabilities for Antibody Pipeline An...il 9 InNexus Biotechnology Inc. (Toronto Stock Ex...velopment company commercializing the next generat...gy, Dynamic Cross Linking (DXL(TM)), announced tod... its lead preclinical candidate DXL625 (CD20) for ...

Other Medicine Technology:Pharmacyclics Initiates Phase 1 Clinical Trial of Novel Oral Btk Inhibitor for Refractory B-cell Non-Hodgkin's Lymphoma 2 Pharmacyclics Initiates Phase 1 Clinical Trial of Novel Oral Btk Inhibitor for Refractory B-cell Non-Hodgkin's Lymphoma 3 Pharmacyclics Initiates Phase 1 Clinical Trial of Novel Oral Btk Inhibitor for Refractory B-cell Non-Hodgkin's Lymphoma 4 Pharmacyclics Initiates Phase 1 Clinical Trial of Novel Oral Btk Inhibitor for Refractory B-cell Non-Hodgkin's Lymphoma 5 AACR Data Highlights InNexus Preclinical Antibody Candidate 2

Pharmacyclics Initiates Phase 1 Clinical Trial of Novel Oral Btk Inhibitor for Refractory B-cell Non-Hodgkin's Lymphoma AACR Data Highlights InNexus Preclinical Antibody Candidate

(Date:11/21/2009)...ilvia Lopez, by her attorney MICHAEL STEWART FRANK...eme Court, New York County, bearing Index # 112888...underwent a routine transesophageal echocardiogram... an HIV infected scope exposing her to HIV. ,...eing discharged from the procedure and arriving ba...

(Date:11/21/2009)...parel company launches men,s lab coats at Medica 2...ente, Calif. (PRWEB) November 21, 2009 -- Medelita...y announced the launch of its men,s lab coats, whi...ational trade fair for the medical industry held i...n,s collection with three varying lab coat styles,...

(Date:11/20/2009)...erstanding Brain Wiring and Diseases ,, WASHING... Schmahmann, Professor of Neurology at Harvard Med...eneral Hospital in Boston, on Thursday, November 1...field of study called "Connectivity" at the launch...is an award-winning leader in the field of the cer...

(Date:11/20/2009)...men in Competitive Re-election Battles Could Be in... Washington, DC (Vocus) November 20, ...ection next year in races deemed to be competitive...t voting for House Speaker Nancy Pelosi’s he...rnational/ O’Leary Report poll. (The Poll ...

(Date:11/20/2009)...wire-USNewswire/ -- Samuel Gladding is no Scrooge,...to be "happy" during the holidays. As a licensed p...ounseling and chair of the Department of Counselin...h shows that it is the pressure to be happy that o...he holidays. ,, That,s why he,s challenging the...

Breaking Medicine News(10 mins):Health News:Patient Files Suit Against St. Vincent's Hospital in New York City as a Result of the Alleged Use by the Hospital of an HIV Infected Device During a Routine Procedure 2 Health News:Medelita Introduces Men's Lab Coat Collection 2 Health News:Medelita Introduces Men's Lab Coat Collection 3 Health News:MINDlink Foundation Launches to Connect the Cerebellum to Cures 2 Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 2 Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 3 Health News:Why Holidays Don't Have To Be 'Happy' 2

[0] Patient Files Suit Against St. Vincent's Hospital in New York City as a Result of the Alleged Use by the Hospital of an HIV Infected Device During a Routine Procedure [0] Medelita Introduces Men's Lab Coat Collection [0] MINDlink Foundation Launches to Connect the Cerebellum to Cures [0] Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill [0] Why Holidays Don't Have To Be 'Happy'

... tea daily can protect you from developing skin ca...re research// to strengthen the findings. Te...the body against Squamous cell carcinomas and Basa... or even years, the researchers say. Squamou...

...ed today says school playgrounds and athletic faci... childhood obesity//, but many are locked and inac...oor and minority neighborhoods. The study is... 1,556 girls in the sixth grade in six metropolita...

...e Virginia Tech sure had the whole world reaching ...university. //An incident unbelievable, the shooti...hed out with deep sympathy and anguish for the fam...t. It will sure take its time for the loss and gri...

...ement therapy are more likely to be diagnosed with...ng //to a study published in the Lancet* today. ...the biggest study of its kind in the world, show t... one additional death from ovarian cancer. T...

...ns for men no-scalpel vasectomies are highly prefe... //there is no definitive statistics to claim abou...een stressed about the importance of the training....he University of Otago in Christchurch, New Zealan...

... with excitement about a possible cure for HIV/AID... Announcing the discovery of a peptide (chain of ...ney dialysis patients, lead researcher Frank Kirch... more and more.” Accordingly, this compound found ...

Other Medicine News:Health News:School Playgrounds and Athletic Facilities Helps To Fight Childhood Obesity 2 Health News:Support for Trauma and Grief 2 Health News:HRT Increases Incidence and Deaths from Ovarian Cancer 2 Health News:No-scalpel Vasectomies by Skilled Surgeons may Speed Recovery 2 Health News:No-scalpel Vasectomies by Skilled Surgeons may Speed Recovery 3 Health News:HIV/AIDS- Possible Cure From Within 2

Drinking Tea Could Protect Your Skin School Playgrounds and Athletic Facilities Helps To Fight Childhood Obesity Support for Trauma and Grief HRT Increases Incidence and Deaths from Ovarian Cancer No-scalpel Vasectomies by Skilled Surgeons may Speed Recovery HIV/AIDS- Possible Cure From Within

Universal I/A handpiece - Titanium (Binkhorst Tip)

Universal I/A handpiece - Titanium (Straight Tip, Size: 16g Outer Cannula)

PremierEdge™ Clear Cornea Knives - Parallel Sides

Terry-Schanzlin Astigmatome - Vacuum Speculum

Medicine Products:

Universal I/A handpiece - Titanium (Binkhorst Tip)Universal I/A handpiece - Titanium (Straight Tip, Size: 16g Outer Cannula)PremierEdge™ Clear Cornea Knives - Parallel Sides Terry-Schanzlin Astigmatome - Vacuum Speculum

Dong-A PharmTech Co., Ltd. Announces Portal Hypertension Clinical Trial Wit...(underserved portalhypertension market. ...),Health